SUNHO BIO-B 02898Hong Kong Stock Exchange

Suspended: Oct 9 · Delayed · Hong Kong Stock Exchange
SUNHO BIO-B (02898) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Sunho Biologics, Inc.
Market
HKEX Main Board
Listing Date
2024-05-24
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG8572S1021

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
ROE (Last FY)-15.62%72/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
ZHANG Feng Executive Director
JIANG Xiaoling Executive Director
CHAN Heung Wing Anthony Independent Non-Executive Director
FENG Lan Independent Non-Executive Director
SHI Luwen Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-07-22.

About this page

This page shows SUNHO BIO-B (02898) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.